||
埃博拉临床试验信息分析(21项)
地区、国家分布
|
Found 21 studies with search of: | EBOLA |
Acute Lung Injury 1 study
Adenoviridae Infections 3 studies
Communicable Diseases 15 studies
Coronary Artery Disease 4 studies
Coronary Disease 4 studies
Ebola Virus Disease 12 studies
Fever 14 studies
Hemorrhagic Fever 14 studies
Hemorrhagic Fever, Ebola 14 studies
Hemorrhagic Fevers, Viral 14 studies
Infant, Newborn, Diseases 1 study
Infant, Premature, Diseases 1 study
Infection 15 studies
Influenza, Human 1 study
Lung Diseases 1 study
Lung Injury 1 study
Marburg Hemorrhagic Fever 2 studies
Marburg Virus Disease 2 studies
RNA Virus Infections 13 studies
Respiration Disorders 1 study
Respiratory Tract Diseases 1 study
Smallpox 1 study
Stomatitis 1 study
Syndrome 1 study
Vesicular Stomatitis 1 study
Viral Hemorrhagic Fever 14 studies
Virus Diseases 19 studies
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed | Evaluating an Ebola and a Marburg Vaccine in Uganda
| ||||
2 | Recruiting | Phase 1 Trial of Ebola Vaccine in Mali
| ||||
3 | Active, not recruiting | A Study to Assess a New Ebola Vaccine, cAd3-EBO Z
| ||||
4 | Completed | Experimental Vaccine for Prevention of Ebola Virus Infection
| ||||
5 | Recruiting | Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)
| ||||
6 | Completed | Ebola and Marburg Virus Vaccines
| ||||
7 | Recruiting | Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults
| ||||
8 | Recruiting | Safety and Immunogenicity of Prime-Boost VSV Ebola Vaccine in Healthy Adults
| ||||
9 | Completed | Experimental Ebola Vaccine Trial
| ||||
10 | Not yet recruiting | A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.
| ||||
11 | Not yet recruiting | A Prospective, Open Label, Observational Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Infection Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Infection
| ||||
12 | Recruiting | VSV-ZEBOV Geneva Vaccine Trial
| ||||
13 | Recruiting | Vaccine Treatment for Ebola Virus in Healthy Adults
| ||||
14 | Not yet recruiting | An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease
| ||||
15 | Recruiting | A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland
| ||||
16 | Completed | Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
| ||||
17 | Terminated | Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion
| ||||
18 | Withdrawn | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
| ||||
19 | Suspended | Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802
| ||||
20 | Completed | Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study
|
21 | Completed | VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases
|
参考文献
中新社华盛顿11月26日电(记者 刁海洋)美国国家卫生研究院(NIH)26日宣布,首个埃博拉疫苗成功通过临床试验,被证实安全有效。
这一成果当天发表在美国的一家医学杂志上。文章称,NIH下属的过敏与传染病研究院与葛兰素史克公司的研究人员从埃博拉病毒中提取出部分基因,并植入人体细胞内,最终制成疫苗。
http://news.sciencenet.cn/htmlnews/2014/11/308111.shtm
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-11-23 23:02
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社